The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with Massdevice +7.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Hologic Inc. (NSDQ:HOLX) won a round in its patent infringement battle with Conceptus Inc. (NSDQ:CPTS) after a federal judge ruled that Hologic can use a letter Conceptus claimed was covered under attorney-client privilege.
Mountain View, Calif.-based Conceptus sued its Bedford, Mass.-based competitor in May 2009, alleging infringement of five patents covering its Essure female sterilization system.
Conceptus Inc. (NSDQ:CPTS) and Hologic Inc. (NSDQ:HOLX) agreed to narrow the scope of a patent infringement lawsuit over their respective female sterilization treatments, dropping all unfair competition claims and counter-claims from the case.
Mountain View, Calif.-based Conceptus sued its Bedford, Mass.-based competitor in May 2009, alleging infringement of five patents for its Essure female sterilization system.
Hologic Inc. (NSDQ:HOLX) fought back against rival Conceptus Inc. (NSDQ:CPTS) in a lawsuit accusing Conceptus of falsely marking one of its products with patents owned by Hologic.
The lawsuit, filed in the U.S. District Court for Massachusetts, accuses Conceptus of marking its Essure female sterilization system as protected by two patents covering Hologic’s competing Adiana system.
Conceptus Inc. (NSDQ:CPTS) posted fourth-quarter sales of $37 million for the three months ended Dec. 31, 2009, up 29.6 percent compared with $28.5 million during the same period in 2008. Net income rose 66.9 percent to $6.6 million, compared with $4 million during QYY Q4 2008:
Conceptus® Reports Fourth Quarter Sales
Growth of 30%, Diluted EPS of $0.21
